PanGenomic Health Aktie Logo
CA69842E4031
A40U4J
LL3.HM

PanGenomic Health Aktie

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, PanGenomic Health Aktie had revenue of €0 and net profit of -€422.65K
(EUR) June 2026
YoY
Revenue 0 -
Gross profit -97.44 0.47%
Net profit -422.65K 70.74%
EBITDA -415.52K 68.21%

Fundamentals

Metric Value
Market capitalization
€2.89M
Number of shares
14.05M
52-week high/low
€1.60 - €0.12
Dividends No
Beta
-0.85
P/E ratio
-1.59
PEG ratio
-0.02
P/B ratio
-3.07
P/S ratio
0.00

Company profile

Name
PanGenomic Health Aktie
CEO
Maryam Marissen

Ticker symbols

Exchange Symbol
Hamburg
LL3.HM
München
LL3.MU
🍪

Parqet  uses cookies. Learn more